adplus-dvertising
Connect with us

Investment

Healthcare Investments Are Slowing Down – Forbes

Published

 on


The global economy is currently at a turbulent intersection, one that even the most celebrated economic pundits and fiscal savants cannot seem to accurately navigate. While some say that the economy is headed for a “soft-landing,” others exclaim that a full-blown recession is inevitable.

The healthcare industry is by no means immune to these economic pressures. In fact, healthcare has had many years of its own unique fiscal challenges— those that were uniquely exacerbated by the Covid-19 pandemic. Regardless, over the last decade, venture capital (VC) funding and investments in healthcare have actually been quite strong, as investors were eager to invest in cutting-edge technologies and the next generation of care delivery. Now, however, these same sources of funding are starting to slow down in fear of economic turmoil, indicating that rapid innovation in healthcare may indeed take a pause.

A recent report by Rock Health indicated that there has been a significant slow down in healthcare funding, specifically in the areas of the digital health. The report authors explain: “For the digital health sector, 2022 was a downhill ride—one that we think signals the tail end of a macro funding cycle centered around the COVID-19-era investment boom […] 2022’s total funding among US-based digital health startups amounted to $15.3B across 572 deals, with an average deal size of $27M. Not only did 2022’s annual funding total come in at just over half of 2021’s $29.3B2, but it also just squeaked past 2020’s $14.7B sum. Notably, 2022’s year’s Q4 $2.7B total was less than half of last year’s Q4 raise ($7.4B).”

As the report alludes to, the digital health industry has seen an incredible boom over the last decade. The U.S. Food and Drug Administration (FDA) defines digital health broadly as anything which “includes categories such as mobile health (mHealth), health information technology (IT), wearable devices, telehealth and telemedicine, and personalized medicine.” And given its relatively broad scope, digital health tools have had tremendous impact over a variety of healthcare sub-industries, ranging from diagnostics and care delivery, to augmented healthcare insights and tools for data-driven decision making.

One of the most notable areas has been the boom of telehealth and virtual health services, which was especially fueled by stay-at-home and social distancing restrictions during the Covid-19 pandemic. Notable names in this space that captured an immense amount of attention are Teladoc and Amwell. These companies continue to innovate in the virtual care space.

In terms of “big tech,” companies such as Amazon, Walmart, Google, and even Oracle have continued their investments in digital health and healthcare technology. For example, Amazon’s bold purchase of One Medical will undoubtedly give the eCommerce giant a significant leap forward into healthcare delivery. Leveraging its incredible technology platform, millions of insights on consumer retail patterns, and last-mile logistics network, this venture by Amazon will definitely be a game-changer.

However, even “big tech” has not been immune to economic pressures. Last year, Google announced that it would be moving many of its employees from its Health division into other positions around the company, indicating a “shake-up” of its health vertical. Similarly, Amazon itself shut down its “Care” business, citing that Amazon Care was likely not the best way to deliver valuable impact to its clients or patients. These moves candidly illustrate that even the most successful companies have to execute challenging decisions to maintain fiscal responsibility.

Assuredly, economic conditions will not improve overnight, and a sense of uncertainty will likely last for the coming months, if not for years. The healthcare system as a whole is already skating on thin ice, balancing razor-thin margins while also dealing with macro-economic issues such as increased costs, a significant labor shortage, and changing consumer preferences. Given these circumstances, investments in healthcare innovation and technology will likely also slow down in the near future. However, as history has indicated, the healthcare industry is resilient and relentless. Undoubtedly, both the economy and consumers will find a way to reinvigorate it in due time, and innovation will be bountiful, yet again.

Adblock test (Why?)

728x90x4

Source link

Continue Reading

Economy

Energy stocks help lift S&P/TSX composite, U.S. stock markets also up

Published

 on

 

TORONTO – Canada’s main stock index was higher in late-morning trading, helped by strength in energy stocks, while U.S. stock markets also moved up.

The S&P/TSX composite index was up 34.91 points at 23,736.98.

In New York, the Dow Jones industrial average was up 178.05 points at 41,800.13. The S&P 500 index was up 28.38 points at 5,661.47, while the Nasdaq composite was up 133.17 points at 17,725.30.

The Canadian dollar traded for 73.56 cents US compared with 73.57 cents US on Monday.

The November crude oil contract was up 68 cents at US$69.70 per barrel and the October natural gas contract was up three cents at US$2.40 per mmBTU.

The December gold contract was down US$7.80 at US$2,601.10 an ounce and the December copper contract was up a penny at US$4.28 a pound.

This report by The Canadian Press was first published Sept. 17, 2024.

Companies in this story: (TSX:GSPTSE, TSX:CADUSD)

The Canadian Press. All rights reserved.

Source link

Continue Reading

Economy

S&P/TSX gains almost 100 points, U.S. markets also higher ahead of rate decision

Published

 on

 

TORONTO – Strength in the base metal and technology sectors helped Canada’s main stock index gain almost 100 points on Friday, while U.S. stock markets climbed to their best week of the year.

“It’s been almost a complete opposite or retracement of what we saw last week,” said Philip Petursson, chief investment strategist at IG Wealth Management.

In New York, the Dow Jones industrial average was up 297.01 points at 41,393.78. The S&P 500 index was up 30.26 points at 5,626.02, while the Nasdaq composite was up 114.30 points at 17,683.98.

The S&P/TSX composite index closed up 93.51 points at 23,568.65.

While last week saw a “healthy” pullback on weaker economic data, this week investors appeared to be buying the dip and hoping the central bank “comes to the rescue,” said Petursson.

Next week, the U.S. Federal Reserve is widely expected to cut its key interest rate for the first time in several years after it significantly hiked it to fight inflation.

But the magnitude of that first cut has been the subject of debate, and the market appears split on whether the cut will be a quarter of a percentage point or a larger half-point reduction.

Petursson thinks it’s clear the smaller cut is coming. Economic data recently hasn’t been great, but it hasn’t been that bad either, he said — and inflation may have come down significantly, but it’s not defeated just yet.

“I think they’re going to be very steady,” he said, with one small cut at each of their three decisions scheduled for the rest of 2024, and more into 2025.

“I don’t think there’s a sense of urgency on the part of the Fed that they have to do something immediately.

A larger cut could also send the wrong message to the markets, added Petursson: that the Fed made a mistake in waiting this long to cut, or that it’s seeing concerning signs in the economy.

It would also be “counter to what they’ve signaled,” he said.

More important than the cut — other than the new tone it sets — will be what Fed chair Jerome Powell has to say, according to Petursson.

“That’s going to be more important than the size of the cut itself,” he said.

In Canada, where the central bank has already cut three times, Petursson expects two more before the year is through.

“Here, the labour situation is worse than what we see in the United States,” he said.

The Canadian dollar traded for 73.61 cents US compared with 73.58 cents US on Thursday.

The October crude oil contract was down 32 cents at US$68.65 per barrel and the October natural gas contract was down five cents at US$2.31 per mmBTU.

The December gold contract was up US$30.10 at US$2,610.70 an ounce and the December copper contract was up four cents US$4.24 a pound.

— With files from The Associated Press

This report by The Canadian Press was first published Sept. 13, 2024.

Companies in this story: (TSX:GSPTSE, TSX:CADUSD)

The Canadian Press. All rights reserved.

Source link

Continue Reading

Economy

S&P/TSX composite down more than 200 points, U.S. stock markets also fall

Published

 on

 

TORONTO – Canada’s main stock index was down more than 200 points in late-morning trading, weighed down by losses in the technology, base metal and energy sectors, while U.S. stock markets also fell.

The S&P/TSX composite index was down 239.24 points at 22,749.04.

In New York, the Dow Jones industrial average was down 312.36 points at 40,443.39. The S&P 500 index was down 80.94 points at 5,422.47, while the Nasdaq composite was down 380.17 points at 16,747.49.

The Canadian dollar traded for 73.80 cents US compared with 74.00 cents US on Thursday.

The October crude oil contract was down US$1.07 at US$68.08 per barrel and the October natural gas contract was up less than a penny at US$2.26 per mmBTU.

The December gold contract was down US$2.10 at US$2,541.00 an ounce and the December copper contract was down four cents at US$4.10 a pound.

This report by The Canadian Press was first published Sept. 6, 2024.

Companies in this story: (TSX:GSPTSE, TSX:CADUSD)

The Canadian Press. All rights reserved.

Source link

Continue Reading

Trending